Synthesis of a C20-Deoxygenated Spirangien Derivative for Target Identification

Nadine Bluhm; Markus Kalesse

doi:10.1055/s-0034-1379980

Synlett, Table of Contents

Synlett 2015; 26(06): 797-801
DOI: 10.1055/s-0034-1379980

letter

Synthesis of a C20-Deoxygenated Spirangien Derivative for Target Identification

Nadine Bluhm

^aInstitute for Organic Chemistry and Center of Biomolecular Drug Research (BMWZ), Leibniz Universität Hannover, Schneiderberg 1B, 30167 Hannover, Germany Email: Markus.Kalesse@oci.uni-hannnover.de

,

Markus Kalesse*

^aInstitute for Organic Chemistry and Center of Biomolecular Drug Research (BMWZ), Leibniz Universität Hannover, Schneiderberg 1B, 30167 Hannover, Germany Email: Markus.Kalesse@oci.uni-hannnover.de

^bHelmholtz Centre for Infection Research, Inhoffenstr. 7, 38124 Braunschweig, Germany

› Author Affiliations

Abstract

All articles of this category

Abstract

The synthesis of a C20-deoxygenated spirangien derivative is described that allows the incorporation of various affinity labels for target identification of this potent natural product. The synthesis takes advantage of two major building blocks that can be accessed in 8 and 14 steps, respectively. The endgame joins both fragments through a selective aldol reaction and final protecting group manipulations furnish the target molecule.

Key words

natural product synthesis - spirangien - aldol reaction - target identification

Full Text

References

References and Notes

1a Höfle G, Bedorf N, Gerth K, Reichenbach H. German Patent DE4211056C1, 1995
1b Niggemann J, Bedorf N, Flörke U, Steinmetz H, Gerth K, Reichenbach H, Höfle G. Eur. J. Org. Chem. 2005; 5013

2 Reboll MR, Ritter B, Sasse F, Niggemann J, Frank R, Nourbakhsh M. ChemBioChem 2012; 13: 409
3 Frank B, Knauber J, Steinmetz H, Scharfe M, Blöcker H, Beyer S, Müller R. Chem. Biol. 2007; 14: 221

4a Paterson I, Findlay DD, Noti C. Chem. Commun. 2008; 6408
4b Paterson I, Findlay AD, Noti C. Chem. Asian J. 2009; 4: 594
4c Paterson I, Findlay AD, Anderson EA. Angew. Chem. Int. Ed. 2014; 46: 6699

5a Lorenz M, Kalesse M. Org. Lett. 2008; 10: 4371
5b Lorenz M, Kalesse M. Tetrahedron Lett. 2007; 48: 2905

6 Guérinot A, Lepesqueux G, Sablé S, Reymond S, Cossy J. J. Org. Chem. 2010; 75: 5151
7 Newton S, Carter CF, Pearson CM, de C Alves L, Lange H, Thansandote P, Ley SV. Angew. Chem. Int. Ed. 2014; 53: 4915
8 Gregg C, Gunawan C, Yi NgA. W, Wimala S, Wickremasinghe S, Rizzacasa MA. Org. Lett. 2013; 3: 516
9 Evans DA, Clark JS, Metternich R, Novack VJ, Shepard GS. J. Am. Chem. Soc. 1990; 112: 866
10 Evans DA, Chapman KT, Carreira EM. J. Am. Chem. Soc. 1988; 110: 3560

11a Studte C, Breit B. Angew. Chem. Int. Ed. 2008; 47: 5451
11b Brand GJ, Studte C, Breit B. Org. Lett. 2009; 20: 4668

12a Paterson I, Tillyer RD. Tetrahedron Lett. 1992; 33: 4233
12b Arikan F, Li J, Menche D. Org. Lett. 2008; 10: 3521

13a Smidt J, Hafner W, Jira R, Sedlmeier J, Sieber R, Rüttinger R, Kojer H. Angew. Chem. 1959; 71: 176
13b Tsuji J. Palladium Reagents and Catalysts . Wiley; New York: 2004. 1st ed. 29
13c Cornell CN, Sigman MS. Inorg. Chem. 2007; 46: 1903

14 Lorenz M, Bluhm N, Kalesse M. Synthesis 2009; 3061
15 Spiroketal 4: The methylated linear precursor 18 (12.0 mg, 10.6 μmol) was dissolved in MeOH (1 mL) and CH₂Cl₂ (0.2 mL) at 0 °C and PPTS (27.0 mg, 106.1 μmol) was added. The reaction mixture was stirred for 16 h and was quenched by the addition of distilled H₂O (2 mL). The layers were separated, the aqueous layer was extracted with EtOAc (5 × 3 mL), the combined organic layers were dried over MgSO₄, filtered and the solvent was removed in vacuo. The reddish crude product was purified via column chromatography (MeOH–CH₂Cl₂, 1:50) and additional HPLC (conditions: column: Nucleodur C 18 ISIS, 5 μm; eluent: MeCN–H₂O; program: 5 min 50% MeCN, from 50% MeCN to 70% MeCN in 40 min, 15 min with 70% MeCN, from 70% MeCN to 80% MeCN in 5 min, from 80% MeCN to 100% MeCN in 5 min with a flow rate of 3 mL/min; t _R = 66.5 min) and the spiroketal 4 (1.3 mg, 1.9 μmol, 18%) was obtained; R_f 0.24 (MeOH–CH₂Cl₂, 1:75); [α]²⁰ ₅₈₉ +2.0 (c = 0.20, CHCl₃). ¹H NMR (500 MHz, CD₃OD): δ = 7.34 (d, J = 4.4 Hz, 4 H), 7.26–7.30 (m, 1 H), 7.24 (d, J = 8.6 Hz, 2 H), 6.85–6.89 (m, 2 H), 4.49–4.55 (m, 2 H), 4.36–4.46 (m, 2 H), 4.18 (dd, J = 10.3, 2.1 Hz, 1 H), 3.77 (s, 3 H), 3.74 (dd, J = 9.4, 3.7 Hz, 1 H), 3.62 (dd, J = 9.0, 4.5 Hz, 1 H), 3.48–3.54 (m, 3 H), 3.39 (dd, J = 9.3, 7.7 Hz, 1 H), 3.34–3.36 (m, 1 H), 3.32–3.33 (m, 1 H), 3.31–3.32 (m, 3 H), 2.28–2.35 (m, 1 H), 2.21–2.26 (m, 1 H), 2.14–2.19 (m, 1 H), 1.92–1.99 (m, 1 H), 1.86–1.91 (m, 1 H), 1.81–1.86 (m, 1 H), 1.78 (dd, J = 12.3, 4.5 Hz, 1 H), 1.60–1.64 (m, 1 H), 1.52–1.57 (m, 1 H), 1.38–1.46 (m, 2 H), 1.31–1.33 (m, 1 H), 1.02 (d, J = 6.7 Hz, 3 H), 0.96–1.00 (m, 6 H), 0.83 (d, J = 6.8 Hz, 3 H), 0.80 (d, J = 6.5 Hz, 3 H), 0.78 (d, J = 6.8 Hz, 3 H). ¹³C NMR (125 MHz, CD₃OD): δ = 160.7, 139.9, 132.0 (2 × C), 130.4 (2 × C), 129.4 (2 × C), 128.8 (2 × C), 128.7, 114.7, 99.4, 78.9, 78.7, 77.5, 76.4, 74.9, 74.3, 73.6, 73.5, 73.0, 55.6, 55.6, 39.0, 38.2, 37.7, 37.5, 35.0, 32.5, 32.5, 30.6, 28.7, 17.4, 15.3, 14.3, 10.9, 9.9, 4.9. HRMS (ESI): m/z [M + H⁺] calcd for C₂₉H₆₁O₈: 657.4366; found: 657.4360.

Supplementary Material

Supporting Information